Plato Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.1M Buy
20,799
+2,674
+15% +$2.71M 1.29% 10
2025
Q4
$19.6M Buy
18,125
+633
+4% +$605K 1.28% 10
2025
Q3
$13.2M Hold
17,492
0.9% 12
2025
Q2
$13.6M Buy
17,492
+1,037
+6% +$806K 1.02% 13
2025
Q1
$13.7M Sell
16,455
-860
-5% -$716K 1.16% 11
2024
Q4
$13.4M Buy
17,315
+511
+3% +$423K 0.99% 12
2024
Q3
$14.9M Buy
16,804
+1,481
+10% +$1.33M 1.21% 10
2024
Q2
$13.9M Buy
15,323
+783
+5% +$626K 1.29% 9
2024
Q1
$11.3M Buy
14,540
+13,539
+1,353% +$9.64M 1.17% 10
2023
Q4
$584K Buy
+1,001
New +$584K 0.72% 27

Other funds holding LLY

Plato Investment Management's LLY Position: Q1 2026 in Review

Plato Investment Management increased its Eli Lilly (LLY) stake by 15% in Q1 2026, buying an estimated $2.71M and bringing the position to 20,799 shares worth $19.1M. The position accounts for 1.29% of the portfolio, ranked #10.

Plato Investment Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $19.6M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Plato Investment Management held 20,799 shares of Eli Lilly worth $19.1M as of Q1 2026.
  • Plato Investment Management bought 2,674 Eli Lilly shares in Q1 2026, an estimated $2.71M.
  • Eli Lilly made up 1.29% of Plato Investment Management's portfolio in Q1 2026, its #10 holding.
  • Plato Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Plato Investment Management's Eli Lilly position peaked at $19.6M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.